Abstract
Health-related quality of life (HRQOL) is arguably one of the most important measures in evaluating effectiveness of clinical treatments. At present, there is no disease-specific outcome measure to assess the HRQOL of children, adolescents and young adults with Neurofibromatosis Type 1 (NF1). This study aimed to develop the items and support the content validity for the Pediatric Quality of Life Inventory™ (PedsQL™) NF1 Module for children, adolescents and young adults. The iterative process included multiphase qualitative methods including a literature review, survey of expert opinions, semi-structured interviews, cognitive interviews and pilot testing. Fifteen domains were derived from the qualitative methods, with content saturation achieved, resulting in 115 items. The domains include skin, pain, pain impact, pain management, cognitive functioning, speech, fine motor, balance, vision, perceived physical appearance, communication, worry, treatment, medicines and gastrointestinal symptoms. This study is limited because all participants are recruited from a single-site. Qualitative methods support the content validity for the PedsQL™ NF1 Module for children, adolescents and young adults. The PedsQL™ NF1 Module is now undergoing national multisite field testing for the psychometric validation of the instrument development.
Similar content being viewed by others
Abbreviations
- NF1:
-
Neurofibromatosis type 1
- PedsQL:
-
Pediatric quality of life inventory
- QOL:
-
Quality of life
- NF:
-
Neurofibromatosis
- HRQOL:
-
Health-related quality of fife
- PRO:
-
Patient reported outcome
- PROMIS:
-
Patient reported outcomes measurement information system
References
Williams VC et al (2009) Neurofibromatosis type 1 revisited. Pediatrics 123(1):124–133
Lu-Emerson C, Plotkin SR (2009) The Neurofibromatoses. Part 1: NF1. Rev Neurol Dis 6(2):E47–E53
Friedman JM (1999) Epidemiology of neurofibromatosis type 1. Am J Med Genet 89(1):1–6
Friedman JM (2002) Neurofibromatosis 1: clinical manifestations and diagnostic criteria. J Child Neurol 17(8):548–554 (discussion 571–572, 646–651)
Wimmer K (2005) Neurofibromatosis: the most frequent hereditary tumor predisposition syndrome. Wien Med Wochenschr 155(11–12):273–280
Jett K, Friedman JM (2010) Clinical and genetic aspects of neurofibromatosis 1. Genet Med 12(1):1–11
Anderson JL, Gutmann DH (2015) Neurofibromatosis type 1. Handb Clin Neurol 132:75–86
Evans DG et al (2002) Malignant peripheral nerve sheath tumours in neurofibromatosis 1. J Med Genet 39(5):311–314
Ferner RE, Gutmann DH (2013) Neurofibromatosis type 1 (NF1): diagnosis and management. Handb Clin Neurol 115:939–955
Sabatini C et al (2015) Treatment of neurofibromatosis type 1. Curr Treat Options Neurol 17(6):355
Karajannis MA, Ferner RE (2015) Neurofibromatosis-related tumors: emerging biology and therapies. Curr Opin Pediatr 27(1):26–33
Guyatt GH et al (1989) Measuring quality of life in clinical trials: a taxonomy and review. Cmaj 140(12):1441–1448
Vranceanu AM et al (2015) Quality of life among children and adolescents with neurofibromatosis 1: a systematic review of the literature. J Neurooncol 122(2):219–228
Vranceanu AM et al (2013) Quality of life among adult patients with neurofibromatosis 1, neurofibromatosis 2 and schwannomatosis: a systematic review of the literature. J Neurooncol 114(3):257–262
Wells GA et al (2011) Validity of quality of life measurement tools—from generic to disease-specific. J Rheumatol Suppl 88:2–6
Nutakki K et al (2013) Development of the adult PedsQL neurofibromatosis type 1 module: initial feasibility, reliability and validity. Health Qual Life Outcomes 11:21
Lasch KE et al (2010) PRO development: rigorous qualitative research as the crucial foundation. Qual Life Res 19(8):1087–1096
Brod M, Tesler LE, Christensen TL (2009) Qualitative research and content validity: developing best practices based on science and experience. Qual Life Res 18(9):1263–1278
Irwin DE et al (2009) Cognitive interviewing methodology in the development of a pediatric item bank: a patient reported outcomes measurement information system (PROMIS) study. Health Qual Life Outcomes 7:3
U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research, U.S. Department of Health and Human Services FDA Center for Biologics Evaluation and Research, Department of Health and Human Services FDA Center for Devices and Radiological Health (2006) Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes 4:79
Varni JW et al (2012) PedsQL gastrointestinal symptoms module item development: qualitative methods. J Pediatr Gastroenterol Nutr 54(5):664–671
Panepinto JA, Torres S, Varni JW (2012) Development of the PedsQL sickle cell disease module items: qualitative methods. Qual Life Res 21(2):341–357
Franciosi JP et al (2012) Development of the pediatric quality of life inventory eosinophilic esophagitis module items: qualitative methods. BMC Gastroenterol 12:135
Varni JW et al (2006) The PedsQL in pediatric cerebral palsy: reliability, validity, and sensitivity of the generic core scales and cerebral palsy module. Dev Med Child Neurol 48(6):442–449
Varni JW et al (2003) The PedsQL in type 1 and type 2 diabetes: reliability and validity of the pediatric quality of life inventory generic core scales and type 1 diabetes module. Diabetes Care 26(3):631–637
Varni JW et al (2002) The PedsQL in pediatric cancer: reliability and validity of the Pediatric Quality of Life Inventory Generic Core Scales, Multidimensional Fatigue Scale, and Cancer Module. Cancer 94(7):2090–2106
Varni JW et al (2002) The PedsQL in pediatric rheumatology: reliability, validity, and responsiveness of the Pediatric Quality of Life Inventory Generic Core Scales and Rheumatology Module. Arthritis Rheum 46(3):714–725
Varni JW et al (2004) The PedsQL in pediatric asthma: reliability and validity of the Pediatric Quality of Life Inventory generic core scales and asthma module. J Behav Med 27(3):297–318
Goldstein SL et al (2008) Measuring health-related quality of life in children with ESRD: performance of the generic and ESRD-specific instrument of the Pediatric Quality of Life Inventory (PedsQL). Am J Kidney Dis 51(2):285–297
Palmer SN et al (2007) The PedsQL Brain Tumor Module: initial reliability and validity. Pediatr Blood Cancer 49(3):287–293
Weissberg-Benchell J et al (2010) Pediatric health-related quality of life: Feasibility, reliability and validity of the PedsQL transplant module. Am J Transplant 10(7):1677–1685
Follansbee-Junger KW et al (2016) Development of the PedsQL Epilepsy Module: Focus group and cognitive interviews. Epilepsy Behav 62:115–120
Varni JW et al (2013) Content validity of the PedsQL 3.2 Diabetes Module in newly diagnosed patients with Type 1 diabetes mellitus ages 8–45. Qual Life Res 22(8):2169–2181
Varni JW The PedsQL measurement model for the pediatric quality of life inventory. PedsQL 1998–2016 [cited 2016 May 27]. http://www.pedsql.org/
PROMIS Measures cited 2016. http://www.nihpromis.org/measures/selectinginstrument
NeuroQOL 2013 cited 2016. http://www.neuroqol.org/WhatandWhy/BankDevelopment/Pages/default.aspx
Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 30(6):473–483
Chren MM (2012) The Skindex instruments to measure the effects of skin disease on quality of life. Dermatol Clin 30(2):231–236 (xiii)
Lewis-Jones MS, Finlay AY (1995) The Children’s Dermatology Life Quality Index (CDLQI): initial validation and practical use. Br J Dermatol 132(6):942–949
Hogikyan ND, Sethuraman G (1999) Validation of an instrument to measure voice-related quality of life (V-RQOL). J Voice 13(4):557–569
Rinkel RN et al (2008) Speech Handicap Index in patients with oral and pharyngeal cancer: better understanding of patients’ complaints. Head Neck 30(7):868–874
Paz SH et al (2013) Development of a vision-targeted health-related quality of life item measure. Qual Life Res 22(9):2477–2487
DeWalt DA et al (2007) Evaluation of item candidates: the PROMIS qualitative item review. Med Care 45(5 Suppl 1):S12–S21
Varni JW et al (2010) PROMIS Pediatric Pain Interference Scale: an item response theory analysis of the pediatric pain item bank. J Pain 11(11):1109–1119
Irwin DE et al (2010) Sampling plan and patient characteristics of the PROMIS pediatrics large-scale survey. Qual Life Res 19(4):585–594
Yeatts KB et al (2010) Construction of the Pediatric Asthma Impact Scale (PAIS) for the Patient-Reported Outcomes Measurement Information System (PROMIS). J Asthma 47(3):295–302
Irwin DE et al (2010) An item response analysis of the pediatric PROMIS anxiety and depressive symptoms scales. Qual Life Res 19(4):595–607
Varni JW, Thompson KL, Hanson V (1987) The Varni/Thompson Pediatric Pain Questionnaire. I. Chronic musculoskeletal pain in juvenile rheumatoid arthritis. Pain 28(1):27–38
Varni JW, Limbers CA, Burwinkle TM (2007) Impaired health-related quality of life in children and adolescents with chronic conditions: a comparative analysis of 10 disease clusters and 33 disease categories/severities utilizing the PedsQL 4.0 Generic Core Scales. Health Qual Life Outcomes 5:43
Guest G, Bunce A, Johnson L (2006) How many interviews are enough? An experiment with data saturation variability. Field Methods 18(1):59–82
Funding
This study was fully funded by the Neurofibromatosis Therapeutic Acceleration Program (NTAP) at Johns Hopkins University School of Medicine, Baltimore, MD
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Dr. Varni holds the copyright and the trademark for the Pediatric Quality of Life Inventory™ (PedsQL™) and receives financial compensation from the Mapi Research Trust, which is a non-profit research institute that charges distribution fees to for-profit companies that use the PedsQL™. All other authors have no conflicts of interests.
IRB approval
The Institutional Review Board at Indiana University, Indianapolis, approved this study (Protocol # 1403632840).
Rights and permissions
About this article
Cite this article
Nutakki, K., Varni, J.W., Steinbrenner, S. et al. Development of the pediatric quality of life inventory neurofibromatosis type 1 module items for children, adolescents and young adults: qualitative methods. J Neurooncol 132, 135–143 (2017). https://doi.org/10.1007/s11060-016-2351-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-016-2351-2